comenityMED to launch Resilient Professional Foot Supports
The innovative new product will be displayed at the ACOG Annual Meeting in Nashville, TN, May 3-6, 2019 in booth 1902. Resilient Professional Foot Supports are the first
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XThe innovative new product will be displayed at the ACOG Annual Meeting in Nashville, TN, May 3-6, 2019 in booth 1902. Resilient Professional Foot Supports are the first
In the study of 504 consecutive patients, Zigler and colleagues found no secondary surgery requirements for device failure and a relatively low reoperation rate of 5.5%—including the learning
“This indication is the latest example of LENSAR responding to the needs and feedback from our customers, those refractive cataract surgeons looking to deploy from a full arsenal
It uses an enhanced deep-learning technique to detect over 15 types of cardiac arrhythmias along with beat-by-beat morphology computation which include ventricular arrhythmias, ventricular ectopic beats and all
The collaboration will allow BlueStar users to connect their wearables, apps, and in-home health devices directly to the platform – enabling deeper engagement and better self-management of one’s
threadz is one of the first PDO sutures for tissue elevation that has been registered according to the existing Medical Device Law. The safety and efficacy performance of
The results were presented at the ARVO Imaging in the Eye Conference by Jennifer Lim, MD, Marion H. Schenk Esq. Chair and Professor of Ophthalmology and Director of
The momentous flight was a collaboration between transplant physicians and researchers at the University of Maryland School of Medicine (UMSOM) in Baltimore; aviation and engineering experts at the
The VERDICT study demonstrated that patients with type 2 diabetes who switched to V-Go can improve their average blood sugar levels (A1c) with less insulin. VERDICT is a
DUOBRII is the first and only topical lotion that contains a unique combination of halobetasol propionate and tazarotene in one formulation. In a year-long safety study, patients used